ONGOING ENROLLMENT • 90-DAY ACNE RESEARCH
Angry Skin?
It's Time for a Different Approach.
Breakouts can be frustrating at any age. Discover a research opportunity exploring HOCl-based products for teens and adults experiencing mild, moderate, or severe acne.
• Participation subject to eligibility review
Be Part of the Next Chapter in Acne Research
A 90-day at-home trial for teens and adults, with simple digital check-ins and support from the HOCl research team.
No routine office visits required.
START HERE
Get to Know the Angry Skin Trial
Watch our introduction to learn what we're studying, who can apply, and what participation looks like.
WHO IT'S FOR
Acne Doesn't Have One Story.
Neither do the people experiencing it. We're welcoming teens and adults across a range of acne experiences.
Teens With Acne
Teen participants experiencing mild, moderate, or more severe acne are welcome to apply.
Adults With Acne
From recurring breakouts to persistent adult acne, adults across a range of acne experiences may apply.
Adult-Onset & Perimenopause
Including women navigating adult-onset breakouts and skin changes during perimenopause.
Current use of an antibiotic such as doxycycline does not automatically exclude an applicant. Individuals who are pregnant or currently receiving cancer treatment are not eligible under the stated trial criteria. Final eligibility is determined by the research team.
THE RESEARCH
Meet HOCl: The Focus of Our Study.
Hypochlorous acid (HOCl) is an antimicrobial compound being explored in this acne research program. The trial involves topical Exclusivité products alongside Factor 14 oral and mucosal formulations, including a nasal mist and oral solution.
Researchers are gathering information on participants' experiences, skin outcomes, and tolerability over time. The purpose is to learn how these formulations perform—not to promise a particular result.
What makes this trial different?
✓ Multiple HOCl product formats being studied
✓ 90 days of consistent participation
✓ Digital photo and assessment check-ins
✓ Support from the research team
✓ Participation from home
SIMPLE FROM START TO FINISH
How the Trial Works
01
Submit Your Application
Complete a short online application for eligibility review.
02
Review & Next Steps
If approved, the research team coordinates secure clinical review, prescribing when appropriate, and product shipment.
03
Participate for 90 Days
Use products as instructed and complete quick digital photo and questionnaire check-ins.
Participants generally complete the process in approximately 90–120 days, according to the trial overview.
COMMON QUESTIONS
Questions? We've Got Answers.
Teens and adults with mild, moderate, or severe acne may apply, including adults experiencing adult-onset breakouts during perimenopause. Final eligibility is determined by the research team.
Yes. Current doxycycline use does not automatically exclude an applicant; the research team makes the final eligibility determination.
According to the supplied trial criteria, people who are pregnant or currently receiving cancer treatment cannot participate. Additional eligibility conditions may be assessed by the team.
The trial is designed for remote participation, with digital photos, assessments, and questions rather than routine office visits.
Product participation lasts 90 days. The complete process may take about 90–120 days.
Enrollment is ongoing for upcoming 90-day trial groups.
YOUR SKIN STORY MATTERS
Ready to Be Part of the Research?
Help contribute to what researchers learn about HOCl-based acne care for teens and adults. Start with a short application.
• Participation subject to eligibility review